University Medical Centre Ljubljana: Polycystic Ovary Syndrome trials

The registry lists 11 Polycystic Ovary Syndrome studies with University Medical Centre Ljubljana as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 4 9No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Endocrine Disruptors, Toxic and Essential Chemical Elements and Polycystic Ovary SyndromeCompletedNCT06968455
• Long Term Metformin in Women With Polycystic Ovary SyndromeCompletedNCT04043221
• The Effect of a Liraglutide on IVF in Obese PCOSCompletedNCT03353948Phase 4
• Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary SyndromeCompletedNCT03122041Phase 4
• Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight LossCompletedNCT02941445Phase 4
• Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of ObesityCompletedNCT02909933Phase 4
• Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOSCompletedNCT02683226Phase 4
• PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary SyndromeCompletedNCT02187250Phase 4
• PDE-4 Inhibitor Roflumilast and Polycystic Ovary SyndromeCompletedNCT02037672Phase 4
• Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on MetforminCompletedNCT01911468Phase 4
• Polycystic Ovary Syndrome and LiraglutideCompletedNCT01899430Phase 4